Regeneron Pharmaceuticals Inc Regn Q3 2018 Earnings Conference Call Transcript | Latest News RSS feed

Regeneron Pharmaceuticals Inc Regn Q3 2018 Earnings Conference Call Transcript - Latest News


Regeneron Pharmaceuticals Inc (REGN) Q3 2018 Earnings Conference Call Transcript

Welcome to the Regeneron Pharmaceuticals Q3 2018 Earnings Conference Call. My name is John, and I'll be your operator for today's call. (Operator Instructions) And I will now turn the call over to Man... read more

Is a Beat in the Cards for Allergan (AGN) in Q3 Earnings?

Factors to Consider On the second-quarter conference call ... company has an Earnings ESP of +0.56% and is a Zacks #2 Ranked stock. You can see the complete list of today’s Zacks #1 Rank stocks here. ... read more

Regeneron Pharmaceuticals Inc Market Cap:

Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is ... read more

Looking for another news?


Regeneron Pharma: FDA Approves Asthma Indication For Dupixent - Quick Facts

(RTTNews) - Regeneron Pharmaceuticals, Inc. (REGN) and Sanofi announced the U.S. Food and Drug Administration has approved Dupixent (dupilumab) as an add-on maintenance therapy in patients with modera... read more


Regeneron (REGN) Beats on Q3 Earnings & Sales, Shares Up

Regeneron Pharmaceuticals, Inc. REGN reported third-quarter ... Exelixis’ earnings per share estimates increased from 26 cents to 43 cents for 2017 and increased from 63 cents to 70 cents for 2018 ove... read more

Regeneron Downgrade Highlights at Least Some Risks

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) seems to have held up rather well against an ... the firm’s John Newman slashed his Regeneron price target to $525 from $700 in his call. The reasons that ... read more

Regeneron Pharmaceuticals (REGN) Q3 2018 Results - Earnings Call Transcript

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q3 2018 Earnings Call ... LLC Welcome to the Regeneron Pharmaceuticals Q3 2018 Earnings Conference Call. My name is John and I'll be your operator ... read more

Regeneron Pharmaceuticals Inc EPS Estimates for Next Fiscal Year

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's. For more detailed information on specific periods, view the following: 1) Analyst... read more

Regeneron And Sanofi Say FDA Accepts Priority Review BLA For Cemiplimab

(RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) and Sanofi (SNYNF ... The target action date for the FDA decision is October 28, 2018. The BLA submission is based on a Phase 2 pivotal, single-arm, o... read more

Regeneron and Sanofi Plan to Appeal Amgen Patent Verdict

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) saw its shares halted on Wednesday afternoon after a jury ruled in favor of Amgen Inc. (NASDAQ: AMGN) on a cholesterol drug patent. However, Regeneron and ... read more

Regeneron Pharmaceuticals (REGN) Q2 2018 Results - Earnings Call Transcript

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q2 2018 Earnings Call August 2 ... Raymond - Piper Jaffray & Co. Welcome to the Regeneron Pharmaceuticals Second Quarter 2018 Earnings Conference Call. My ... read more

Regeneron Pharmaceuticals Inc (REGN) Q3 2018 Earnings Conference Call Transcript

Image source: The Motley Fool. Regeneron Pharmaceuticals Inc (NASDAQ: REGN) Q3 2018 Earnings Conference Call Nov. 06, 2018, 8:30 a.m. ET Operator Welcome to the Regeneron Pharmaceuticals Q3 2018 Earni... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us